Physiological profile and limitations in exercise in idiopathic pulmonary fibrosis

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 36, Issue 4, 2016, Pages 270-278

  Vainshelboim, Baruch ^a,b   Oliveira, Jose ^b   Fox, Benjamin Daniel ^a,c   Adir, Yochai ^d   Ollech, Jacob Eliezer ^a   Kramer, Mordechai Reuven ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PORTO   (Portugal)

^c TEL AVIV UNIVERSITY   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

6 minute walk test; Aerobic exercise capacity; Cardiopulmonary exercise test; Functional capacity; Idiopathic pulmonary fibrosis

Indexed keywords

CARBON MONOXIDE;

30 SECOND CHAIR STAND TEST; 6 MINUTE WALK TEST; 8 FOOT UP AND GO TEST; AEROBIC CAPACITY; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; COMORBIDITY; DIAGNOSTIC TEST; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; FATTY ACID DESATURATION; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HUMAN; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG MINUTE VOLUME; LUNG VENTILATION; MALE; PHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPIROMETRY; TOTAL LUNG CAPACITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ANAEROBIC THRESHOLD; COMPLICATION; DYSPNEA; EXERCISE TOLERANCE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; REST; SYSTOLE; VITAL CAPACITY; WALK TEST;

AGED; ANAEROBIC THRESHOLD; DYSPNEA; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; PULMONARY EMPHYSEMA; REST; SYSTOLE; VENTRICULAR FUNCTION, LEFT; VITAL CAPACITY; WALK TEST;

EID: 84968645103     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000177     Document Type: Article

References (49)

1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183 (6): 788-824.
2. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007; 176 (3): 277-284.
3. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis. 2008; 3: 8.
4. du Bois RM, Albera C, Bradford WZ, et al. 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014; 43 (5): 1421-1429.
5. Holland AE. Exercise limitation in interstitial lung disease- mechanisms, significance and therapeutic options. Chron Respir Dis. 2010; 7 (2): 101-111.
6. Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med. 2004; 25 (3): 435-453.
7. Fell CD, Liu LX, Motika C, et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009; 179 (5): 402-407.
8. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161 (2, pt 1): 646-664.
9. Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise trainingbased pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration. 2014; 88 (5): 378-388.
10. Vainshelboim B, Oliveira J, Fox BD, Soreck Y, Fruchter O, Kramer MR. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015; 193 (3): 345-354.
11. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93 (3): 580-586.
12. Papiris SA, Daniil ZD, Malagari K, et al. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med. 2005; 99 (6): 755-761.
13. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation. 1991; 84 (3)(suppl): I280-I287.
14. Schiller NB. Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin. 1990; 8 (2): 277-287.
15. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009; 34 (6): 1219-1263.
16. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005; 26 (4): 720-735.
17. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005; 26 (1): 153-161.
18. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26 (3): 511-522.
19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16: 5-40.
20. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991; 144 (5): 1202-1218.
21. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26 (5): 948-968.
22. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003; 167 (2): 211-277.
23. Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009; 77 (1): 3-17.
24. Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007; 29 (1): 185-209.
25. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014: 114-160.
26. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of Exercise Testing and Interpretation. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 183-241.
27. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010; 122 (2): 191-225.
28. Guazzi M, Adams V, Conraads V, et al. EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012; 126 (18): 2261-2274.
29. Burdon JG, Killian KJ, Jones NL. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax. 1983; 38 (10): 778-784.
30. Gallagher CG, Younes M. Breathing pattern during and after maximal exercise in patients with chronic obstructive lung disease, interstitial lung disease, and cardiac disease, and in normal subjects. Am Rev Respir Dis. 1986; 133 (4): 581-586.
31. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166 (1): 111-117.
32. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998; 158 (5, pt 1): 1384-1387.
33. Rikli RE, Jones CJ. The Senior Fitness Test Manual. Champaign, IL: Human Kinetics; 2001: 111-151.
34. Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012; 24 (3): 69-71.
35. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014; 108 (1): 203-210.
36. Kenn K, Gloeckl R, Behr J. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis - a review. Respiration. 2013; 86 (2): 89-99.
37. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2011; 16 (8): 1196-1202.
38. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008; 13 (3): 394-399.
39. Enright PL. The six-minute walk test. Respir Care. 2003; 48 (8): 783-785.
40. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008; 63 (6): 549-554.
41. Boutou AK, Pitsiou GG, Trigonis I, et al. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology. 2011; 16 (3): 451-458.
42. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996; 109 (6): 1566-1576.
43. Arena R, Sietsema KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation. 2011; 123 (6): 668-680.
44. Nishiyama O, Taniguchi H, Kondoh Y, et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest. 2005; 127 (6): 2028-2033.
45. Jackson R, Ramos C, Gupta C, Gomez-Marin O. Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients. Respir Med. 2010; 104 (12): 1919-1928.
46. Jackson RM, Gomez-Marin OW, Ramos CF, et al. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung. 2014; 192 (3): 367-376.
47. Murray JA, Waterman LA, Ward J, Baird JC, Mahler DA. Perceptual and physiologic responses during treadmill and cycle exercise in patients with COPD. Chest. 2009; 135 (2): 384-390.
48. Marquis N, Debigare R, Bouyer L, et al. Physiology of walking in patients with moderate to severe chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2009; 41 (8): 1540-1548.
49. Hsia D, Casaburi R, Pradhan A, Torres E, Porszasz J. Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J. 2009; 34 (3): 605-615.